封面
市场调查报告书
商品编码
1634237

全球 Omega-3 补充品市场 - 2024 - 2031

Global Omega-3 Supplements Market - 2024 - 2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023 年,全球 Omega-3 补充剂市场规模达到 72 亿美元,预计到 2031 年将达到 141 亿美元,2024-2031 年预测期间复合年增长率为 7.1%。

随着消费者越来越意识到 EPA 和 DHA 等 omega-3 脂肪酸的健康益处,omega-3 补充剂市场正在经历强劲增长,这些脂肪酸可支持心臟健康和大脑功能并减少发炎。随着注重健康的消费者寻求预防性解决方案,对 omega-3 的需求持续增长,特别是由于心血管疾病的盛行率不断上升和人口老化。

美国食品药物管理局建议每天摄取膳食补充剂中 EPA 和 DHA 的总量不超过 5 克,这对于塑造 Omega-3 补充剂市场发挥着至关重要的作用。此外,植物性选择的不断增加,例如源自藻类的 omega-3,正在满足纯素食和环保意识的消费者的需求。随着全球对健康的关注日益加深,omega-3 补充剂将在全球预防性健康策略中发挥重要作用。

美国成年人每天摄取 1.98 克 ALA,超过了建议摄取量,但 EPA 和 DHA 分别只有 35 毫克/天和 76 毫克/天,远低于建议量。 EPA 和 DHA 摄取量的巨大差距支持了北美在全球 omega-3 补充剂市场的持续主导地位,因为消费者越来越多地转向补充剂来满足这些重要的营养需求。

动力学

提高消费者健康意识

由于消费者越来越认识到 omega-3 脂肪酸的健康益处,特别是对心臟健康、大脑功能和减少发炎的益处,该市场正在经历快速成长。随着越来越多的人关注预防性健康并寻求主动管理健康的方法,Omega-3 补充剂正在成为一种主食,支持市场的持续扩张。慢性病的盛行率不断上升,特别是心血管问题和人口老化进一步刺激了需求。

补充剂消费进一步反映出天然健康解决方案日益增长的趋势。根据负责任营养委员会的数据,2021 年Omega-3 等特种补充剂占补充剂消费量的46%。 25% 飙升至70%。慢性病风险较高的人尤其推动了这个趋势。

新的创新

omega-3 补充剂的创新对于推动全球市场的成长至关重要。提高 omega-3 脂肪酸生物利用度和吸收的技术进步正在满足消费者对更有效、更方便的健康解决方案日益增长的需求。一个典型的例子是 Aker BioMarine 的 PL+ EPA/DHA 配方,与传统鱼油相比,该配方可显着提高 EPA 和 DHA 的吸收 10.5 倍。

这款突破性配方结合了磷虾磷脂和鱼油,即使不需要脂肪餐,也能实现更好的消化和吸收。透过迎合越来越多的低脂饮食人群并提供更有效的补充剂,此类创新正在扩大市场范围。随着消费者的健康意识越来越强,寻求有科学根据、可持续且高效的产品,PL+ 技术等创新正在加速市场成长。

高成本和永续性挑战

优质 Omega-3 产品的高成本是全球 Omega-3 补充剂市场最重要的阻碍因素之一。优质 Omega-3 补充剂,特别是那些源自鱼油的补充剂,由于萃取过程昂贵且需要高品质、浓缩的 EPA 和 DHA,因此生产成本通常较高。因此,这些产品的售价较高,对价格敏感的消费者难以负担。

此外,对可持续且符合道德来源的 Omega-3 的需求不断增长,导致价格进一步上涨。过度捕捞的担忧和环境永续发展的努力正在推动更好的采购实践,例如使用负责任养殖的鱼类或藻类油等植物性替代品。虽然这些替代品通常被认为更环保,但它们的生产成本可能更高,从而进一步推高价格。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 提高消费者健康意识
      • 新的创新
    • 限制
      • 高成本和永续性挑战
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • DMI 意见

第 6 章:按来源

  • 鱼油
  • 磷虾油
  • 海藻油
  • 其他的

第 7 章:按形式

  • 软胶囊
  • 液体
  • 粉末

第 8 章:按类型

  • 有机的
  • 传统的

第 9 章:依功能分类

  • 心血管健康
  • 大脑与认知健康
  • 眼睛健康
  • 关节健康
  • 其他的

第 10 章:按配销通路

  • 超市/大卖场
  • 便利商店
  • 专卖店
  • 网上商店
  • 其他的

第 11 章:最终用户

  • 成年人
  • 孕妇
  • 孩子们
  • 老年
  • 其他的

第 12 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第13章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 14 章:公司简介

  • Nordic Naturals Inc
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • RB Health (US) LLC
  • Aker BioMarine Human Ingredients AS
  • dsm-firmenich
  • NOW Foods
  • Pharmavite LLC
  • Carlson Labs
  • The Coromega Company
  • NutriGold Inc
  • Barlean's Organic Oils, LLC

第 15 章:附录

简介目录
Product Code: FB5089

Overview

Global Omega-3 Supplements Market reached US$ 7.2 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 7.1 % during the forecast period 2024-2031.

The omega-3 supplements market is experiencing robust growth, driven by increasing consumer awareness of the health benefits of omega-3 fatty acids like EPA and DHA, which support heart health and brain function and reduce inflammation. As health-conscious consumers seek preventive solutions, demand for omega-3s continues to rise, particularly due to the growing prevalence of cardiovascular diseases and the aging population.

The US Food and Drug Administration's recommendation of consuming no more than 5 grams per day of EPA and DHA combined from dietary supplements plays a crucial role in shaping the Omega-3 supplements market. Additionally, the expanding availability of plant-based options, such as algae-derived omega-3s, is meeting the needs of vegan and environmentally-conscious consumers. As the global focus on wellness intensifies, omega-3 supplements are poised to remain vital to preventive health strategies worldwide.

American adults consume 1.98 grams/day of ALA, exceeding the recommended intake, but only 35 mg/day of EPA and 76 mg/day of DHA, well below recommended levels. This significant gap in EPA and DHA intake supports North America's continued dominance in the global omega-3 supplements market, as consumers increasingly turn to supplements to meet these vital nutritional needs.

Dynamics

Increasing Consumer Health Consciousness

The market is experiencing rapid growth, driven by rising consumer awareness of the health benefits of omega-3 fatty acids, particularly for heart health, brain function and inflammation reduction. As more people focus on preventive health and seeking ways to manage their health proactively, omega-3 supplements are becoming a staple, supporting the continued expansion of the market. The increasing prevalence of chronic diseases, especially cardiovascular issues and the aging population have further fueled demand.

Supplements consumption is further reflecting a growing trend toward natural health solutions. According to the Council for Responsible Nutrition, specialty supplements like Omega-3s accounted for 46% of supplement consumption in 2021. The market growth is also linked to the broader increase in dietary supplement use worldwide, which has surged from 25% to 70% over the past 40 years. Populations at higher risk for chronic conditions are particularly driving this trend.

New Innovations

Innovations in omega-3 supplementation are pivotal in driving the growth of the global market. Advances in technology that enhance the bioavailability and absorption of omega-3 fatty acids are meeting the increasing consumer demand for more effective and convenient health solutions. A prime example is Aker BioMarine's PL+ EPA/DHA formulation, which significantly boosts the absorption of EPA and DHA by 10.5 times compared to traditional fish oil.

The breakthrough formulation, which combines krill phospholipids and fish oil, allows for better digestion and absorption, even without needing a fatty meal. By catering to the growing number of individuals on low-fat diets and offering a more efficient supplement, such innovations are expanding the market's reach. As consumers become more health-conscious and seek scientifically-backed, sustainable and efficient products, innovations like PL+ technology are accelerating market growth.

High Costs and Sustainability Challenges

The high cost of quality Omega-3 products is one of the most significant hindering factors for the global Omega-3 supplements market. Premium Omega-3 supplements, particularly those derived from fish oil, often have higher production costs due to the expensive extraction processes and the need for high-quality, concentrated EPA and DHA. As a result, these products are sold at a premium price, making them less affordable for price-sensitive consumers.

Additionally, the growing demand for sustainable and ethically sourced Omega-3s has led to further price increases. Overfishing concerns and environmental sustainability efforts are pushing for better sourcing practices, such as using responsibly farmed fish or plant-based alternatives like algae oil. While these alternatives are often considered more eco-friendly, they can be costlier to produce, further driving up prices.

Segment Analysis

The global Omega-3 supplements market is segmented based on source, form, type, functionality, distribution channel, end-user and region.

High Concentration Of Essential Fatty Acids in Fish Oil

The global Omega-3 supplements market is segmented based on source into fish oil, krill oil, algae oil and others. The fish oil segment dominates the global omega-3 supplements market due to its high concentration of essential fatty acids, EPA and DHA, which are widely recognized for their health benefits, including improving heart health, reducing inflammation and supporting brain function. Fish oil is the most bioavailable and concentrated source of these Omega-3s, making it the preferred choice for consumers.

Extensive research and strong scientific evidence have built consumer trust in its efficacy, ensuring its position as the leading source of Omega-3 supplements. Additionally, fish oil is more cost-effective than alternatives like krill oil and algae oil, making it accessible to a larger consumer base, particularly in developing markets leading to new product launches adding to its dominance.

For instance the launch of NOW's Omega-3 Gummy Chews in August 2024. These sugar-free gummies provide 750 mg of fish oil with enhanced bioavailability, meeting strict purity and potency standards. Offering an affordable, high-quality health solution, they cater to consumers looking for convenient, effective Omega-3 supplementation. The product's availability both online and in select stores underscores the demand for accessible fish oil-based supplements.

Geographical Penetration

Increasing Health-Consciousness in North America

North America's dominance in the global omega-3 supplements market is supported by a well-established culture of health-consciousness, where supplements play a key role in daily wellness routines. According to the 2023 CRN Consumer Survey on Dietary Supplements, 74% of US adults take dietary supplements, with 55% considered regular users, highlighting Americans' mainstream acceptance of supplements.

The trend reflects a growing awareness of the health benefits of products like omega-3s, which are known to support heart health, reduce inflammation and improve brain function. The increasing reliance on supplements is driven by a preventive healthcare mindset, with many consumers seeking to enhance their overall well-being before health issues arise. Region's highly developed healthcare infrastructure and pharmaceutical companies continuously developing and promoting Omega-3 supplements.

Competitive Landscape

The major global players in the market include Nordic Naturals Inc, RB Health (US) LLC, Aker BioMarine Human Ingredients AS, dsm-firmenich, NOW Foods, Pharmavite LLC, Carlson Labs, The Coromega Company, NutriGold Inc and Barlean's Organic Oils, LLC.

Sustainability Analysis

The Omega-3 supplements market is growing rapidly, driven by rising demand for health benefits like improved heart health and brain function. However, the environmental impact of sourcing Omega-3, mainly from fish oil, raises concerns about overfishing. To address this, companies are adopting sustainable practices, such as sourcing from certified fisheries or using algae-based alternatives, to meet consumer demand for eco-friendly products.

As consumers increasingly prioritize ethical sourcing and transparency, brands are focusing on fair labor practices and responsible supply chains. Sustainability is also becoming a key competitive advantage, with many consumers willing to pay more for environmentally and socially responsible products. Balancing health benefits with sustainability is becoming crucial for the long-term success of the market.

Key Developments

  • In March 2024, Epax launched EPAX Omega 3-9-11, a concentrated oil combining omega-3s, omega-9 and omega-11 fatty acids. Using advanced EQP+ Tech, it targets skin health by improving barrier function and reducing inflammation, while offering broader metabolic benefits.
  • In January 2024, Ritual launched Omega-3 DHA + EPA, a vegan supplement with 500 mg of omega-3s in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in France, it's designed for minimal burp-back with a natural citrus flavor. Third-party tested, gluten-free, soy-free and packaged in 100% recycled materials.

Why Purchase the Report?

  • To visualize the global Omega-3 supplements market segmentation based on source, form, type, functionality, distribution channel, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Omega-3 supplements market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global omega-3 supplements market report would provide approximately 86 tables, 88 figures and 211 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Form
  • 3.3. Snippet by Type
  • 3.4. Snippet by Functionality
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by End-User
  • 3.7. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Consumer Health Consciousness
      • 4.1.1.2. New Innovations
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs and Sustainability Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Fish Oil
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Krill Oil
  • 6.4. Algae Oil
  • 6.5. Others

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Soft Gel Capsules
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Liquid
  • 7.4. Powder

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Organic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Conventional

9. By Functionality

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 9.1.2. Market Attractiveness Index, By Functionality
  • 9.2. Cardiovascular Health
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Brain & Cognitive Health
  • 9.4. Eye Health
  • 9.5. Joint Health
  • 9.6. Others

10. By Distribution Channel

  • 10.1. Introduction
  • 10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.3. Market Attractiveness Index, By Distribution Channel
  • 10.4. Supermarkets/Hypermarkets
    • 10.4.1. Introduction
    • 10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.5. Convenience Stores
  • 10.6. Specialty Stores
  • 10.7. Online Stores
  • 10.8. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Adults
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Pregnant Women
  • 11.4. Children
  • 11.5. Elderly
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.10.1. US
      • 12.2.10.2. Canada
      • 12.2.10.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.10.1. Germany
      • 12.3.10.2. U.K.
      • 12.3.10.3. France
      • 12.3.10.4. Italy
      • 12.3.10.5. Spain
      • 12.3.10.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.10.1. Brazil
      • 12.4.10.2. Argentina
      • 12.4.10.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.10.1. China
      • 12.5.10.2. India
      • 12.5.10.3. Japan
      • 12.5.10.4. Australia
      • 12.5.10.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.6.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Nordic Naturals Inc
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. RB Health (US) LLC
  • 14.3. Aker BioMarine Human Ingredients AS
  • 14.4. dsm-firmenich
  • 14.5. NOW Foods
  • 14.6. Pharmavite LLC
  • 14.7. Carlson Labs
  • 14.8. The Coromega Company
  • 14.9. NutriGold Inc
  • 14.10. Barlean's Organic Oils, LLC

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us